Earnings
Inspire Medical Guides To Only Low Single-Digit 2027 Growth After Billing Changes Hit 2026
The sleep apnea implant maker estimates coding problems cost about $120 million this year, and its CEO says much of the disruption is behind it.
Inspire Medical Systems (INSP) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
The sleep apnea implant maker estimates coding problems cost about $120 million this year, and its CEO says much of the disruption is behind it.
SEC Filings
Severance was only $3.1 million of the charge, and the Project Horizon risk warning from the prior quarter is gone.
SEC Filings
The sleep apnea implant maker took a $24.1 million restructuring charge, narrowed its 2026 revenue range and said it plans a return to growth in 2027.